Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4
2(100.0%)
2Total
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02061072Completed

Web-based Application for the Population Pharmacokinetic Service - Phase 1

Role: collaborator

NCT00904709Phase 4Completed

The Assessment of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding Disorders

Role: collaborator

NCT03136003Phase 4Unknown

DDAVP vs. Exercise in Patients With Mild Hemophilia A

Role: collaborator

NCT02199717Completed

An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia

Role: collaborator

All 4 trials loaded